Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence

37

description

Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence. Program Goals. Insulin Deficiency and Glucagon Hypersecretion in T2D. Postprandial Glucagon Is Excessive and Not Corrected by Exogenous Insulin. Incretin Hormome Physiology. Signal Transduction and GLP-1. - PowerPoint PPT Presentation

Transcript of Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence

Page 1: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 2: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 3: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 4: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 5: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 6: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 7: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 8: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 9: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 10: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 11: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 12: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 13: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 14: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 15: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 16: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 17: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 18: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 19: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 20: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 21: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 22: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 23: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 24: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 25: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 26: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 27: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 28: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 29: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 30: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 31: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 32: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 33: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 34: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 35: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 36: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence
Page 37: Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence

The biology of incretin hormones Review Daniel J. …glucagon.com/pdfs/CellMetabolism2006.pdfThe biology of incretin hormones Review Daniel J. Drucker1,* ... an essential enzyme regulating

The biology of incretin hormones Review Daniel J. …glucagon.com/pdfs/CellMetabolism2006.pdfThe biology of incretin hormones Review Daniel J. Drucker1,* ... an essential enzyme regulating

Degradation of the Incretin Hormone Glucagon-Like Peptide ... · Degradation of the Incretin Hormone Glucagon-Like Peptide-1 (GLP-1) by Enterococcus faecalis Metalloprotease GelE

Degradation of the Incretin Hormone Glucagon-Like Peptide ... · Degradation of the Incretin Hormone Glucagon-Like Peptide-1 (GLP-1) by Enterococcus faecalis Metalloprotease GelE

Novel Incretin analogues improve autophagy and …...Novel Incretin analogues improve autophagy and protect from mitochondrial stress induced by rotenone in SH-SY5Y cells Jaishree

Novel Incretin analogues improve autophagy and …...Novel Incretin analogues improve autophagy and protect from mitochondrial stress induced by rotenone in SH-SY5Y cells Jaishree

Insulin plus incretin: A glucose-lowering strategy for ...€¦ · Insulin plus incretin: A glucose-lowering strategy for type 2-diabetes Bo Ahrén ... BASIS FOR INCRETIN THERAPY

Insulin plus incretin: A glucose-lowering strategy for ...€¦ · Insulin plus incretin: A glucose-lowering strategy for type 2-diabetes Bo Ahrén ... BASIS FOR INCRETIN THERAPY

Comparison of efficacy between different incretin based ... Comparison of efficacy between different incretin-based therapies; GLP-1 agonists and DPP-4 inhibitors. Kaustubh Nisal1,

Comparison of efficacy between different incretin based ... Comparison of efficacy between different incretin-based therapies; GLP-1 agonists and DPP-4 inhibitors. Kaustubh Nisal1,

Elevated circulating levels of an incretin hormone, glucagon-like ...

Elevated circulating levels of an incretin hormone, glucagon-like ...

Therapeutic Class Overview Incretin Mimetics mimetics 2014 11.pdf · Therapeutic Class Overview . Incretin Mimetics . Therapeutic Class • Overview/Summary: The glucagon-like peptide-1

Therapeutic Class Overview Incretin Mimetics mimetics 2014 11.pdf · Therapeutic Class Overview . Incretin Mimetics . Therapeutic Class • Overview/Summary: The glucagon-like peptide-1

Supplemental Information Snapin Mediates Incretin … · Supplemental Information Snapin Mediates Incretin Action and Augments Glucose-Dependent Insulin Secretion ... (fludrocortisone)

Supplemental Information Snapin Mediates Incretin … · Supplemental Information Snapin Mediates Incretin Action and Augments Glucose-Dependent Insulin Secretion ... (fludrocortisone)

Prospects of incretin mimetics in therapeutics

Prospects of incretin mimetics in therapeutics

Understanding the science of incretin biology and ...

Understanding the science of incretin biology and ...

Incretin Based Gene Therapy Approaches for Diabetestip.akdeniz.edu.tr/wp-content/uploads/2016/10/... · Incretin based drugs • The incretins are gastrointestinal hormones that work

Incretin Based Gene Therapy Approaches for Diabetestip.akdeniz.edu.tr/wp-content/uploads/2016/10/... · Incretin based drugs • The incretins are gastrointestinal hormones that work

Hypoglycemics, Incretin Enhancers/Mimetics · Hypoglycemics, Incretin Mimetics/Enhancers Therapeutic Class Review (TCR) November 20, 2017 No part of this publication may be reproduced

Hypoglycemics, Incretin Enhancers/Mimetics · Hypoglycemics, Incretin Mimetics/Enhancers Therapeutic Class Review (TCR) November 20, 2017 No part of this publication may be reproduced

Incretin-Based Therapies and Diabetic Retinopathy: Real-World · Incretin-based therapies (IBTs), including glucagon-like peptide-1 receptor agonists (GLP1RA) and dipeptidyl peptidase

Incretin-Based Therapies and Diabetic Retinopathy: Real-World · Incretin-based therapies (IBTs), including glucagon-like peptide-1 receptor agonists (GLP1RA) and dipeptidyl peptidase

ueda2012 -incretin based therapy of type 2 diabetes mellitus_d.adel

ueda2012 -incretin based therapy of type 2 diabetes mellitus_d.adel

Differentiating ux

Differentiating ux

Use of Canagliflozin in Combination With and Compared to Incretin-based … · to incretin-based therapies. Mechanism of SGLT2 Inhibition. In healthy individuals, the kidneys . filter

Use of Canagliflozin in Combination With and Compared to Incretin-based … · to incretin-based therapies. Mechanism of SGLT2 Inhibition. In healthy individuals, the kidneys . filter

Differentiating instruction

Differentiating instruction

Differentiating Instruction: Teaching Differently to ...smpotts.weebly.com/uploads/1/3/4/2/13426405/differentiatedinstruc… · Page 1 Differentiating Instruction Differentiating

Differentiating Instruction: Teaching Differently to ...smpotts.weebly.com/uploads/1/3/4/2/13426405/differentiatedinstruc… · Page 1 Differentiating Instruction Differentiating

Rate of change / Differentiation (3) Differentiating Differentiating Using differentiating Using differentiating.

Rate of change / Differentiation (3) Differentiating Differentiating Using differentiating Using differentiating.

Differentiating math

Differentiating math